Becton, Dickinson and Company

NYSE:BDXB Stock Report

Market Cap: US$70.5b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Becton Dickinson Past Earnings Performance

Past criteria checks 4/6

Becton Dickinson has been growing earnings at an average annual rate of 24.7%, while the Medical Equipment industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 4.7% per year. Becton Dickinson's return on equity is 6.4%, and it has net margins of 8.3%.

Key information

24.7%

Earnings growth rate

23.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate4.7%
Return on equity6.4%
Net Margin8.3%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Becton Dickinson makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:BDXB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2318,8091,5564,7911,266
31 Dec 2218,7381,4864,7511,255
30 Sep 2218,8701,5454,7261,256
30 Jun 2218,9581,4134,7741,324
31 Mar 2218,9241,4304,8451,339
31 Dec 2118,5341,0794,7501,302
30 Sep 2119,1311,5144,7201,279
30 Jun 2119,0661,4864,6321,210
31 Mar 2118,3131,3794,4091,142
31 Dec 2018,2071,5074,3461,117
30 Sep 2016,0742454,1781,039
30 Jun 2016,9177864,2161,067
31 Mar 2017,4149234,3131,057
31 Dec 1917,3557604,3791,044
30 Sep 1917,2901,0814,3341,032
30 Jun 1917,1087844,3451,039
31 Mar 1917,0369264,3531,063
31 Dec 1817,0638944,3251,071
30 Sep 1815,9831594,0291,004
30 Jun 1814,7476213,689947
31 Mar 1813,503-993,325857
31 Dec 1712,2512942,991783
30 Sep 1712,0931,0302,953770
30 Jun 1712,1587592,947807
31 Mar 1712,3211,3142,957827
31 Dec 1612,4191,3092,966823
30 Sep 1612,4839763,005828
30 Jun 1612,3121,1392,966771
31 Mar 1612,2348102,988743
31 Dec 1511,2176882,767690
30 Sep 1510,2826952,563632
30 Jun 159,4108152,350570
31 Mar 158,4481,0792,127529
31 Dec 148,4681,1502,141527
30 Sep 148,4461,1852,145524
30 Jun 148,3459742,117522
31 Mar 148,2399412,102506
31 Dec 138,1699302,091502
30 Sep 138,0549292,059494
30 Jun 137,9201,1142,004490
31 Mar 137,8481,1321,960484
31 Dec 127,7761,1311,934478
30 Sep 127,7081,1101,920472
30 Jun 127,7291,1201,913468

Quality Earnings: BDXB has high quality earnings.

Growing Profit Margin: BDXB's current net profit margins (8.3%) are higher than last year (7.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: BDXB has become profitable over the past 5 years, growing earnings by 24.7% per year.

Accelerating Growth: BDXB's earnings growth over the past year (8.8%) is below its 5-year average (24.7% per year).

Earnings vs Industry: BDXB earnings growth over the past year (8.8%) exceeded the Medical Equipment industry 1.2%.


Return on Equity

High ROE: BDXB's Return on Equity (6.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.